Coronary artery bypass grafting in 2 thrombophilic patients with protein s deficiency

Yen-Michael S Hsu1, George J Despotis

  • 1From the Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, Missouri.

A & a Case Reports
|January 23, 2015
PubMed

Insights

This report details two coronary revascularization cases in patients with coronary artery disease and protein S deficiency. Fresh frozen plasma normalized protein S levels, preventing thrombotic complications without antifibrinolytics.

Area of Science:

  • Cardiology
  • Hematology

Background:

  • Coronary artery disease (CAD) poses significant risks.
  • Protein S deficiency is a hypercoagulable condition impacting surgical outcomes.
  • Managing anticoagulation in CAD patients with protein S deficiency is complex.

Purpose of the Study:

  • To review two cases of coronary revascularization in patients with protein S deficiency.
  • To evaluate the efficacy of fresh frozen plasma in normalizing protein S levels preoperatively.
  • To assess the safety and outcomes of avoiding intraoperative antifibrinolytic treatment.

Main Methods:

  • Case report review of two patients undergoing coronary revascularization.
  • Use of fresh frozen plasma as cardiopulmonary bypass priming fluid to address protein S deficiency.
  • Monitoring for perioperative bleeding and thrombotic complications.

Main Results:

  • Fresh frozen plasma effectively normalized protein S levels prior to extracorporeal circulation.
  • Neither patient experienced perioperative thrombotic complications.
  • Absence of intraoperative antifibrinolytic treatment was well-tolerated.

Conclusions:

  • Fresh frozen plasma is a viable strategy for managing protein S deficiency during coronary revascularization.
  • Coronary revascularization can be safely performed in patients with protein S deficiency.
  • Avoiding antifibrinolytics may be feasible in select cases, balancing bleeding and thrombosis risks.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
437
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
626
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
610
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
475
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K